Shares of Aurobindo Pharma Ltd ended at ₹1,201.25, up by ₹10.10, or 0.85%, on the BSE. Previous Post Pfizer Q3 Results: Profit, margin surge on strong revenue growth; EBITDA up 56% YoY Next Post Linde India rides strong demand and cost efficiency to post 66% jump in Q3 profits Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email, and website in this browser for the next time I comment.Post Comment
